Chemokine receptor modulators
US9314468B2 · kind B2 · utility
20Cited by
10References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 15, 2012 |
| Grant date | Apr 19, 2016 |
| Priority date | — |
| Expiry date | Apr 25, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compounds of Formula (I)and pharmaceutically acceptable salts, solvates, tautomers, stereoisomers, and/or esters thereof. These compounds, and pharmaceutical composition comprising such compounds are useful treating or preventing HIV infections, and in treating proliferative disorders such as inhibiting the metastasis of various cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.